Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.32 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | PIK3C3 | Q8NEB9 | 2/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | HTR7 | P34969 | 1/20 | 0.32 |
| ▸ | HTR6 | P50406 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7558487 | 0.85 | MAPT (0.41) | MAPTHSD17B1HSD17B2PIK3C3HTR1A | |
| SCHEMBL7558786 | 0.83 | MAPT (0.41) | MAPTHSD17B1HSD17B2PIK3C3HTR1A | |
| SCHEMBL7557389 | 0.79 | MAPT (0.43) | MAPTHSD17B1HSD17B2PIK3C3HTR1A | |
| SCHEMBL7558377 | 0.77 | MAPT (0.42) | MAPTHSD17B1HSD17B2PIK3C3HTR1A | |
| SCHEMBL7559768 | 0.76 | MAPT (0.48) | MAPTHSD17B1HSD17B2PIK3C3HTR1A | |
| SCHEMBL7563264 | 0.76 | MAPT (0.38) | MAPTHSD17B1HSD17B2MEN1KMT2A | |
| SCHEMBL7556667 | 0.75 | HSD17B1 (0.34) | MAPTHSD17B1HSD17B2HTR1AHTR2A | |
| SCHEMBL7722529 | 0.73 | HDAC4 (0.46) | MAPTHTR1AHTR2AHTR7HTR6 | |
| SCHEMBL7557878 | 0.72 | MAPT (0.39) | MAPTHSD17B1HSD17B2PIK3C3PIK3CA | |
| SCHEMBL7563319 | 0.71 | HTR1A (0.36) | MAPTHSD17B1HSD17B2HTR1AHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1224172-A1 | DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS | Active Biotech AB (SE) | 2002-07-24 | — | — | EP | disclosed |
| WO-2001030758-A1 | DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS | ACTIVE BIOTECH AB (SE) | 2001-05-03 | — | — | WO | disclosed |